Your browser doesn't support javascript.
loading
Characterizing the exposure-response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma.
Connarn, Jamie N; Witjes, Han; van Zutphen-van Geffen, Marielle; de Greef, Rik; Campbell, Timothy B; Hege, Kristen; Zhou, Simon; Lamba, Manisha.
Afiliação
  • Connarn JN; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Witjes H; Certara Strategic Consulting, Oss, The Netherlands.
  • van Zutphen-van Geffen M; Certara Strategic Consulting, Oss, The Netherlands.
  • de Greef R; Certara Strategic Consulting, Oss, The Netherlands.
  • Campbell TB; Bristol Myers Squibb, San Francisco, California, USA.
  • Hege K; Bristol Myers Squibb, San Francisco, California, USA.
  • Zhou S; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Lamba M; Bristol Myers Squibb, Summit, New Jersey, USA.
CPT Pharmacometrics Syst Pharmacol ; 12(11): 1687-1697, 2023 Nov.
Article em En | MEDLINE | ID: mdl-36794354
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article